Medicine shortages: impact behind numbers

Figures & data

Fig. 1 Elements that determine patient impact of shortages traced using the ECHO model

Table 1 Characteristics of shortages in the Netherlands 2012–2015, n (%)

Table 2 Products in shortage with an overall rate on patient impact of 36 or higher

Fig. 2 Rates on different elements of patient impact for a sample of medicine shortages in the Netherlands (n = 324)

Fig. 3 Rates for economic, clinical, and humanistic outcomes (ECHO) for the medicine shortages

Fig. 4 Box and whisker plots depicting relationships between product characteristics and overall scores on patient impact

Fig. 5 Scores for the overall patient impact of medicine shortages over time

Availability of data and materials

The data on the cohort of the shortages are not publicly available, since data are related to specific products and manufacturers, which is confidential information. Data on costs for medicines as well as age and number of users are third‐party data. These data are not owned by the authors and belong to the Dutch Foundation for Pharmaceutical Statistics (SFK). The SFK welcomes applications from researchers for access to data. Applications are considered by the SFK Supervisory Board. Application forms for data access and further information are available at https://www.sfk.nl/english/foundation‐for‐pharmaceutical‐statistics.